1. Home
  2. GTBP vs AMIX Comparison

GTBP vs AMIX Comparison

Compare GTBP & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GTBP
  • AMIX
  • Stock Information
  • Founded
  • GTBP 1965
  • AMIX 2014
  • Country
  • GTBP United States
  • AMIX United States
  • Employees
  • GTBP N/A
  • AMIX N/A
  • Industry
  • GTBP Biotechnology: Pharmaceutical Preparations
  • AMIX
  • Sector
  • GTBP Health Care
  • AMIX
  • Exchange
  • GTBP Nasdaq
  • AMIX NYSE
  • Market Cap
  • GTBP 6.8M
  • AMIX 7.3M
  • IPO Year
  • GTBP N/A
  • AMIX N/A
  • Fundamental
  • Price
  • GTBP $2.39
  • AMIX $3.14
  • Analyst Decision
  • GTBP Strong Buy
  • AMIX
  • Analyst Count
  • GTBP 1
  • AMIX 0
  • Target Price
  • GTBP $11.00
  • AMIX N/A
  • AVG Volume (30 Days)
  • GTBP 1.3M
  • AMIX 967.7K
  • Earning Date
  • GTBP 11-14-2024
  • AMIX 02-11-2025
  • Dividend Yield
  • GTBP N/A
  • AMIX N/A
  • EPS Growth
  • GTBP N/A
  • AMIX N/A
  • EPS
  • GTBP N/A
  • AMIX N/A
  • Revenue
  • GTBP N/A
  • AMIX N/A
  • Revenue This Year
  • GTBP N/A
  • AMIX N/A
  • Revenue Next Year
  • GTBP N/A
  • AMIX N/A
  • P/E Ratio
  • GTBP N/A
  • AMIX N/A
  • Revenue Growth
  • GTBP N/A
  • AMIX N/A
  • 52 Week Low
  • GTBP $1.72
  • AMIX $2.55
  • 52 Week High
  • GTBP $10.66
  • AMIX $152.00
  • Technical
  • Relative Strength Index (RSI)
  • GTBP 42.95
  • AMIX 41.37
  • Support Level
  • GTBP $2.32
  • AMIX $2.55
  • Resistance Level
  • GTBP $2.63
  • AMIX $3.30
  • Average True Range (ATR)
  • GTBP 0.27
  • AMIX 0.44
  • MACD
  • GTBP -0.05
  • AMIX 0.18
  • Stochastic Oscillator
  • GTBP 33.00
  • AMIX 29.06

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

About AMIX AUTONOMIX MEDICAL INC

Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.

Share on Social Networks: